U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula Ca
Molecular Weight 40.078
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CALCIUM

SMILES

[Ca]

InChI

InChIKey=FAQLAUHZSGTTLN-UHFFFAOYSA-N
InChI=1S/Ca.2H

HIDE SMILES / InChI

Molecular Formula Ca
Molecular Weight 40.078
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Calcium lactate is the salt that consists of two lactate anions for each calcium cation (Ca2+); this salt is used as a calcium supplement to treat hypocalcemia. However, as a source of free calcium, this salt is less convenient than calcium citrate. Calcium lactate inhalation powder also called as PUR118 participated in phase I clinical trials to determine whether this formulation was safe and tolerable in a population of subjects with Cystic Fibrosis (CF). PUR118 also was used in another clinical trials to evaluate its effect on ozone-induced airway Inflammation in healthy normal volunteers in case of Chronic Obstructive Pulmonary Disease (COPD). The obtained results revealed that PUR118 reduced the severity of acute exacerbations in COPD and CF and had the beneficial impacts on mortality, morbidity, and quality of life in affected individuals. However, both studies were discontinued.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Hypocalcemia, chronic (treatment) — Oral calcium supplements provide a source of calcium ion for treating calcium depletion occurring in conditions such as chronic hypoparathyroidism, pseudohypoparathyroidism, osteomalacia, rickets, chronic renal failure, and hypocalcemia secondary to the administration of anticonvulsant medications. When chronic hypocalcemia is due to vitamin D deficiency, oral calcium salts may be administered concomitantly with vitamin D analogs. However, calcium phosphate should not be used in patients with hypoparathyroidism or renal failure, since phosphate levels may be too high and giving more phosphate would exacerbate the condition. Calcium supplements should not be used in hyperparathyroidism, unless the need for a calcium supplement is high and the patient is carefully monitored. For treatment of hypocalcemia, supplementation is preferred
PubMed

PubMed

TitleDatePubMed
Studies on the calcemic effect of intravenous secretin in humans.
1975 Jun
Endothelin-induced changes of secondary messengers in cultured corneal endothelial cells.
2001 Aug
Metal ion-independent association of factor VIII subunits and the roles of calcium and copper ions for cofactor activity and inter-subunit affinity.
2001 Aug 28
Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds.
2001 Dec 21
Complement activation in factor D-deficient mice.
2001 Dec 4
[Acute renal failure caused by hypercalcemia].
2001 Jun 10
Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities.
2001 Nov
Activating mutations of the calcium-sensing receptor: management of hypocalcemia.
2001 Nov
Regression of ventral striatum hypometabolism after calcium/calcitriol therapy in paroxysmal kinesigenic choreoathetosis due to idiopathic primary hypoparathyroidism.
2001 Nov
Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors.
2001 Nov 1
Hypoxia-induced regulation of MAPK phosphatase-1 as identified by subtractive suppression hybridization and cDNA microarray analysis.
2001 Nov 30
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
2001 Oct
Familial intrahepatic cholestasis 1: studies of localization and function.
2001 Oct
Microarray analysis of differential gene expression in lead-exposed astrocytes.
2001 Oct 1
Phosphoinositide 3-kinase isoforms selectively couple receptors to vascular L-type Ca(2+) channels.
2001 Oct 12
Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart.
2001 Oct 26
Regional differences in functional receptor distribution and calcium mobilization in the intact human lens.
2001 Sep
Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism.
2001 Sep
Heterologous expression of the Na(+),K(+)-ATPase gamma subunit in Xenopus oocytes induces an endogenous, voltage-gated large diameter pore.
2001 Sep 1
A diacylglycerol-activated Ca2+ channel in PC12 cells (an adrenal chromaffin cell line) correlates with expression of the TRP-6 (transient receptor potential) protein.
2001 Sep 15
Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze.
2001 Sep 7
Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats.
2002
The role of endogenous human Trp4 in regulating carbachol-induced calcium oscillations in HEK-293 cells.
2002 Apr 19
Interaction of intravenous anesthetics with recombinant human M1-M3 muscarinic receptors expressed in chinese hamster ovary cells.
2002 Dec
CXCR4 expression on monocytes is up-regulated by dexamethasone and is modulated by autologous CD3+ T cells.
2002 Feb
Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene.
2002 Feb
Characterization of basolateral K+ channels underlying anion secretion in the human airway cell line Calu-3.
2002 Feb 1
Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.
2002 Jan 15
Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones.
2002 Jul
Delayed asystolic cardiac arrest after diltiazem overdose; resuscitation with high dose intravenous calcium.
2002 Jul
Transcriptional induction of CYP1A1 by oltipraz in human Caco-2 cells is aryl hydrocarbon receptor- and calcium-dependent.
2002 Jul 5
Human kidney diamine oxidase: heterologous expression, purification, and characterization.
2002 Jun
Expression of functional CCR and CXCR chemokine receptors in podocytes.
2002 Jun 15
Investigation of a functional requirement for isoprenylation by the human prostacyclin receptor.
2002 Mar
Hypertension-related intermyocyte junction remodelling is associated with a higher incidence of low-K(+)-induced lethal arrhythmias in isolated rat heart.
2002 Mar
Alpha(1H) mRNA in single skeletal muscle fibres accounts for T-type calcium current transient expression during fetal development in mice.
2002 Mar 15
Diacylglycerol activates the influx of extracellular cations in T-lymphocytes independently of intracellular calcium-store depletion and possibly involving endogenous TRP6 gene products.
2002 May 15
Neuronal apoptosis inhibitory protein: Structural requirements for hippocalcin binding and effects on survival of NGF-dependent sympathetic neurons.
2002 Nov 4
Molecular cloning and characterization of the human voltage-gated calcium channel alpha(2)delta-4 subunit.
2002 Sep
Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors.
2002 Sep 15
Effects of endothelin B receptor agonists on amyloid beta protein (25-35)-induced neuronal cell death.
2002 Sep 6
A critical interplay between Ca2+ inhibition and activation by Mg2+ of AC5 revealed by mutants and chimeric constructs.
2002 Sep 6
Mechanism of enhanced calcium sensitivity and alpha 2-AR vasoreactivity in chronic NOS inhibition hypertension.
2003 Jan
[Prevention of osteoporosis by foods and dietary supplements. Bioavailability of milk micellar calcium phosphate].
2006 Oct
Henri Moissan: winner of the Nobel Prize for Chemistry 1906.
2006 Oct 20
Dietary calcium source influences body composition, glucose metabolism and hormone levels in a mouse model of postmenopausal obesity.
2009 Jul-Aug
A combination of calcium phosphate and probiotics beneficially influences intestinal lactobacilli and cholesterol metabolism in humans.
2012 Apr
Effect of calcium phosphate and vitamin D₃ supplementation on bone remodelling and metabolism of calcium, phosphorus, magnesium and iron.
2014 Jan 17
Long-term remineralizing effect of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) on early caries lesions in vivo: a systematic review.
2014 Jul
Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
2015 Sep 16
Patents

Sample Use Guides

Proper administration of calcium carbonate or phosphate: Taking tablets 1 to 11/2 hours after meals, unless otherwise directed by physician. Recommended doses for adolescents and adults is 800-1200 mg/day; for pregnat orbreast-feeding females 1200 mg/day.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:13:07 GMT 2025
Edited
by admin
on Mon Mar 31 18:13:07 GMT 2025
Record UNII
SY7Q814VUP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CALCIUM
HSDB   II   MI   ORANGE BOOK   VANDF   WHO-DD  
Systematic Name English
CALCIUM [HSDB]
Preferred Name English
CALCIUM [ORANGE BOOK]
Common Name English
Calcium [WHO-DD]
Common Name English
CALCIUM [VANDF]
Common Name English
CALCIUM [USP-RS]
Common Name English
CALCIUM [MI]
Common Name English
CALCIUM [II]
Common Name English
Classification Tree Code System Code
LOINC 42857-3
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 27037-1
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 32305-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 12181-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
WHO-ATC M05BB05
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 71790-0
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
NCI_THESAURUS C1940
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 27373-0
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 35675-8
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 49005-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 42593-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 9467-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 16525-8
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 27182-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 25583-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
CFR 21 CFR 862.1145
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 35247-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
NDF-RT N0000006512
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 50839-0
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 1998-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 27091-8
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 57335-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 16273-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 14636-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 30527-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
NDF-RT N0000006512
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 74516-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 14637-3
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
WHO-ATC A11GB01
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 2001-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
NDF-RT N0000175597
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 49764-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 14418-8
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 12511-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
NDF-RT N0000020074
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 27172-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 1996-8
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 2002-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 32541-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 13444-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 14417-0
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 57334-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
NDF-RT N0000175901
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 49765-1
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 44716-9
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 29276-3
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 14419-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 58781-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 2003-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 2004-0
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 16518-3
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
CFR 21 CFR 176.170
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 6874-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
WHO-ATC M05BB04
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
WHO-VATC QA11GB01
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 25362-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 17861-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 24518-3
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 15155-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
NDF-RT N0000006512
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 38250-7
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 51610-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 54364-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 18488-7
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 9321-1
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 16526-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 57919-3
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
WHO-ATC A11AA02
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
CFR 21 CFR 101.72
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 53100-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
DSLD 27 (Number of products:15496)
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 1999-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
NDF-RT N0000006512
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 13448-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
WHO-ATC M05BB02
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 18186-7
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 49937-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 35246-8
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
WHO-VATC QA11AA02
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 2000-8
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 50836-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 53124-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 13717-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 54365-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
WHO-ATC A07XA03
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 16527-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 14416-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 87477-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 59000-0
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 53502-1
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 1997-6
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
WHO-ATC M05BB01
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 35248-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 53455-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
LOINC 17862-4
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
Code System Code Type Description
CHEBI
22984
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
FDA UNII
SY7Q814VUP
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
DAILYMED
SY7Q814VUP
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
MESH
D002118
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
ChEMBL
CHEMBL2146121
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
SMS_ID
100000092619
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
RS_ITEM_NUM
1086866
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
EVMPD
SUB13159MIG
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
RXCUI
1895
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY RxNorm
WIKIPEDIA
Calcium
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
MERCK INDEX
m2918
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID9050484
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
CAS
7440-70-2
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
HSDB
273
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
CHEBI
29320
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
ECHA (EC/EINECS)
231-179-5
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
NCI_THESAURUS
C331
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
PUBCHEM
5460341
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
DRUG BANK
DB01373
Created by admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
Related Record Type Details
ACTIVE MOIETY